Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Vendor Neutral Archive (VNA) & PACS Market, by Product Type
1.4.2 Europe Vendor Neutral Archive (VNA) & PACS Market, by Vendor Type
1.4.3 Europe Vendor Neutral Archive (VNA) & PACS Market, by Deployment
1.4.4 Europe Vendor Neutral Archive (VNA) & PACS Market, by End User
1.4.5 Europe Vendor Neutral Archive (VNA) & PACS Market, by Application
1.4.6 Europe Vendor Neutral Archive (VNA) & PACS Market, by Modality
1.4.7 Europe Vendor Neutral Archive (VNA) & PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2020, Aug – 2024, Feb) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
5.1 Europe VNA Market by Country
5.2 Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
5.2.1 Europe Multi-Department VNA Market by Country
5.2.2 Europe Department VNA Market by Country
5.2.3 Europe Multi-Site VNA Market by Country
5.3 Europe PACS Market by Country
5.4 Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
5.4.1 Europe Multi-Department PACS Market by Country
5.4.2 Europe Department PACS Market by Country
5.4.3 Europe Multi-Site PACS Market by Country
Chapter 6. Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
6.1 Europe Independent Vendor Market by Country
6.2 Europe Third-party Vendor Market by Country
Chapter 7. Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
7.1 Europe On-Premise Market by Country
7.2 Europe Cloud-Based Market by Country
7.3 Europe Hybrid Model Market by Country
Chapter 8. Europe Vendor Neutral Archive (VNA) & PACS Market by End User
8.1 Europe Hospitals & Clinics Market by Country
8.2 Europe Diagnostic Centers Market by Country
8.3 Europe Others Market by Country
Chapter 9. Europe Vendor Neutral Archive (VNA) & PACS Market by Application
9.1 Europe Cardiology Market by Country
9.2 Europe Orthopedic Market by Country
9.3 Europe Oncology Market by Country
9.4 Europe Neurology Market by Country
9.5 Europe Obstetrics & Gynecology Market by Country
9.6 Europe Others Market by Country
Chapter 10. Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
10.1 Europe Computed Tomography Market by Country
10.2 Europe Mammography Market by Country
10.3 Europe MRI Market by Country
10.4 Europe Ultrasound Market by Country
10.5 Europe X-Rays Market by Country
10.6 Europe PET Market by Country
Chapter 11. Europe Vendor Neutral Archive (VNA) & PACS Market by Country
11.1 Germany Vendor Neutral Archive (VNA) & PACS Market
11.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.3 Germany Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.4 Germany Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.5 Germany Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.6 Germany Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2 UK Vendor Neutral Archive (VNA) & PACS Market
11.2.1 UK Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.1.1 UK Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.1.2 UK Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.2 UK Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.3 UK Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.4 UK Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.5 UK Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.6 UK Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3 France Vendor Neutral Archive (VNA) & PACS Market
11.3.1 France Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.1.1 France Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.1.2 France Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.2 France Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.3 France Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.4 France Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.5 France Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.6 France Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4 Russia Vendor Neutral Archive (VNA) & PACS Market
11.4.1 Russia Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.1.1 Russia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.1.2 Russia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.2 Russia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.3 Russia Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.4 Russia Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.5 Russia Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.6 Russia Vendor Neutral Archive (VNA) & PACS Market by Modality
11.5 Spain Vendor Neutral Archive (VNA) & PACS Market
11.5.1 Spain Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.5.1.1 Spain Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.5.1.2 Spain Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.5.2 Spain Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.5.3 Spain Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.5.4 Spain Vendor Neutral Archive (VNA) & PACS Market by End User
11.5.5 Spain Vendor Neutral Archive (VNA) & PACS Market by Application
11.5.6 Spain Vendor Neutral Archive (VNA) & PACS Market by Modality
11.6 Italy Vendor Neutral Archive (VNA) & PACS Market
11.6.1 Italy Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.6.1.1 Italy Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.6.1.2 Italy Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.6.2 Italy Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.6.3 Italy Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.6.4 Italy Vendor Neutral Archive (VNA) & PACS Market by End User
11.6.5 Italy Vendor Neutral Archive (VNA) & PACS Market by Application
11.6.6 Italy Vendor Neutral Archive (VNA) & PACS Market by Modality
11.7 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market
11.7.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.7.1.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.7.1.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.7.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.7.3 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.7.4 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by End User
11.7.5 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Application
11.7.6 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
Chapter 12. Company Profiles
12.1 Hyland Software, Inc.
12.1.1 Company Overview
12.1.2 Recent strategies and developments:
12.1.2.1 Partnerships, Collaborations, and Agreements:
12.1.2.2 Product Launches and Product Expansions:
12.2 GE HealthCare Technologies, Inc.
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Segmental and Regional Analysis
12.2.4 Research & Development Expenses
12.2.5 Recent strategies and developments:
12.2.5.1 Partnerships, Collaborations, and Agreements:
12.2.6 SWOT Analysis
12.3 Koninklijke Philips N.V.
12.3.1 Company Overview
12.3.2 Financial Analysis
12.3.3 Segmental and Regional Analysis
12.3.4 Research & Development Expense
12.3.5 Recent strategies and developments:
12.3.5.1 Partnerships, Collaborations, and Agreements:
12.3.6 SWOT Analysis
12.4 Siemens Healthineers AG (Siemens AG)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments:
12.4.5.1 Partnerships, Collaborations, and Agreements:
12.4.6 SWOT Analysis
12.5 Fujifilm Holdings Corporation
12.5.1 Company Overview
12.5.2 Financial Analysis
12.5.3 Segmental and Regional Analysis
12.5.4 Research & Development Expenses
12.5.5 Recent strategies and developments:
12.5.5.1 Product Launches and Product Expansions:
12.5.5.2 Acquisition and Mergers:
12.5.6 SWOT Analysis
12.6 IBM Corporation
12.6.1 Company Overview
12.6.2 Financial Analysis
12.6.3 Regional & Segmental Analysis
12.6.4 Research & Development Expenses
12.6.5 Recent strategies and developments:
12.6.5.1 Product Launches and Product Expansions:
12.6.6 SWOT Analysis
12.7 Carestream Health, Inc. (Onex Corporation)
12.7.1 Company Overview
12.7.2 SWOT Analysis
12.8 Novarad Enterprise Healthcare Solutions
12.8.1 Company Overview
12.8.2 Recent strategies and developments:
12.8.2.1 Partnerships, Collaborations, and Agreements:
12.8.2.2 Product Launches and Product Expansions:
12.8.3 SWOT Analysis
12.9 Canon, Inc. (Canon Medical Systems Corporation)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.9.5 Recent strategies and developments:
12.9.5.1 Partnerships, Collaborations, and Agreements:
12.9.5.2 Product Launches and Product Expansions:
12.9.6 SWOT Analysis
12.10. INFINITT Healthcare Co. Ltd.
12.10.1 Company Overview
12.10.2 Recent strategies and developments:
12.10.2.1 Partnerships, Collaborations, and Agreements:
12.10.2.2 Product Launches and Product Expansions:
12.10.3 SWOT Analysis